GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Price-to-Funds-From-Operations

Pharnext (XPAR:ALPHA) Price-to-Funds-From-Operations : (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pharnext Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Pharnext (XPAR:ALPHA) Business Description

Industry
Traded in Other Exchanges
Address
11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.